ReviewVascular health and risk management2008

Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk.

Byron J Hoogwerf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.